Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 9 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Disrupting insulin receptor function in breast cancer
NIH NATIONAL CANCER INSTITUTE (NCI)
6/1/20 → 5/31/25
Project: Research project
Disrupting Clusters of Circulating Cancer Associated Fibroblasts and Tumor Cells (cCAF/CTCs) to inhibit Breast Cancer Metastasis
5/15/20 → 5/14/21
Project: Research project
APOBEC MUTAGENESIS IN BREAST CANCER
Harris, R., Aihara, H., Harki, D. A., Largaespada, D. A. & Yee, D.
NIH NATIONAL CANCER INSTITUTE (NCI)
8/9/19 → 7/31/24
Project: Research project
Cancer Center Support Grant
Yee, D., AbuSalah, A. M., Basu, S., Beckman, K. B., Bielinsky, A. K., Cooley, S. A., De For, T. E., Falconer, S. N., Felices, M., Griffin, T. J., Hallstrom, T. C., Hatsukami, D. K., Hendrickson, E. A., Hirsch, B. A., Joseph, A. M., Kirstein, M. N., Konety, B. R., Koopmeiners, J., Kuntz, K. M., Lange, C. A., Largaespada, D. A., Le, C. T., LeBeau, A., Lindgren, B. R., Luo, X., Mc Carthy, J. B., McKenna, D. H., Miller, J. S., Moriarity, B. S., Nelson, H. H., O'Sullivan, G., Ondrey, F. G., Pennell, C. A., Petersen, A. J., Peterson, B. A., Peterson, L. A., Sarver, A. L., Shimizu, Y., Siegfried, J. M., Temiz, N. A., Turesky, R., Vogel, R., Wagner, J. E., Wang, J., Weigel, B. J., Weisdorf, D. J., Woo, J. & Yamamoto, M.
NIH NATIONAL CANCER INSTITUTE (NCI)
2/1/19 → 1/31/24
Project: Research project
Research Output
Advances in insulin-like growth factor biology and -directed cancer therapeutics
Fettig, L. M. & Yee, D., 2020, (Accepted/In press) Advances in Cancer Research. Academic Press Inc., (Advances in Cancer Research).Research output: Chapter in Book/Report/Conference proceeding › Chapter
MK-2206 and standard neoadjuvant chemotherapy improves response in patients with human epidermal growth factor receptor 2–positive and/or hormone receptor–negative breast cancers in the I-SPY 2 trial
Chien, A. J., Tripathy, D., Albain, K. S., Symmans, W. F., Rugo, H. S., Melisko, M. E., Wallace, A. M., Schwab, R., Helsten, T., Forero-Torres, A., Stringer-Reasor, E., Ellis, E. D., Kaplan, H. G., Nanda, R., Jaskowiak, N., Murthy, R., Godellas, C., Boughey, J. C., Elias, A. D., Haley, B. B. & 29 others, , Apr 1 2020, In : Journal of Clinical Oncology. 38, 10, p. 1059-1069 11 p.Research output: Contribution to journal › Article
1
Scopus
citations
Erratum to: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint (npj Breast Cancer, (2018), 4, 1, (26), 10.1038/s41523-018-0074-6)
I-SPY2 Investigators, Dec 1 2019, In : npj Breast Cancer. 5, 1, 2.Research output: Contribution to journal › Comment/debate
Open Access
Green tea catechin extract supplementation does not influence circulating sex hormones and insulin-like growth factor axis proteins in a randomized controlled trial of postmenopausal women at high risk of breast cancer
Samavat, H., Wu, A. H., Ursin, G., Torkelson, C. J., Wang, R., Yu, M. C., Yee, D., Kurzer, M. S. & Yuan, J. M., Apr 1 2019, In : Journal of Nutrition. 149, 4, p. 619-627 9 p.Research output: Contribution to journal › Article
1
Scopus
citations
I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer
Wang, H. & Yee, D., Dec 1 2019, In : Current Breast Cancer Reports. 11, 4, p. 303-310 8 p.Research output: Contribution to journal › Review article
Press / Media
Regis, Great Clips want to be industry leaders in reopening process
5/4/20
1 item of Media coverage
Press/Media: Expert Comment
Record drop in cancer deaths may reflect a series of treatment breakthroughs
1/8/20 → 1/9/20
3 items of Media coverage
Press/Media: Expert Comment